TokenPost·
Ideaya Plans IDE849 Cohort for About 90 Patients With Neuroendocrine Cancer

The planned single-arm extension would enroll previously treated patients with gastroenteropancreatic neuroendocrine carcinoma in an ongoing Phase 1/2 study.
Every crypto headline. One feed. Updated every minute.

The planned single-arm extension would enroll previously treated patients with gastroenteropancreatic neuroendocrine carcinoma in an ongoing Phase 1/2 study.